Scribe Therapeutics News and Activities

Acquisition, funding and merger involving Scribe Therapeutics.

• Scribe Therapeutics has filed its IPO. Its stock ticker will be SCTX. (posted on July 7 2026).

View the org chart displaying its 21 main executives

Most searched biographies at Scribe Therapeutics

• Benjamin Oakes, Chief Executive Officer and Director
• Behzad Aghazadeh, Director
• James Watson, Director

Popular executive movements at Scribe Therapeutics

• Aarif Khakoo, Chief Scientific Officer and Head of Research and Development, has left the company  (posted on February 27 2026).

Create your alert
to follow the executive moves at Scribe Therapeutics.

Scribe Therapeutics has 2,430 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Tempus has announced the acquisition of Personalis  (posted on July 20 2026).
• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Scribe Therapeutics

• Scribe → Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
• Scribe → News
• Scribe → News
• Scribe → News
• Scribe → Engineering the Future of Genetic Medicine
• Scribe → Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
• The 2024 PharmaVoice 100
• Press Release – Scribe Therapeutics to Participate in Upcoming Conferences • Scribe
• Top Five Privately Held Gene Editing Therapy Companies
• CRISPR technologies fuelling haematological innovations
• View more press releases Close

Social media about Scribe Therapeutics

• Scribe Therapeutics on Wikipedia, Google News & Yahoo Finance
• Scribe Therapeutics on LinkedIn, X (Twitter) & YouTube